Skip to main content

Advertisement

SpringerLink
Log in

The clinical significance of serum osteocalcin and N-terminal propeptide of type I collagen in predialysis patients with chronic renal failure

  • Original Article
  • Published:
Osteoporosis International Aims and scope Submit manuscript

Abstract

Several new serum markers for bone metabolism have recently become available and are being applied to clinical practice. Their clinical usefulness in predialysis patients with chronic renal failure (CRF), however, has not yet been determined. Serum levels of three bone formation markers—bone alkaline phosphatase (BAP), osteocalcin (OC), and N-terminal propeptide of type I collagen (PINP)—and three bone resorption markers—type I collagen cross-linked N-telopeptide (NTx), deoxypyridinoline (DPD), and pyridinoline (PYD)—were measured simultaneously in 85 predialysis CRF patients (serum creatinine 3.5 ± 1.9 mg/dl, 61.0 ± 10.9 years old, 54 males and 31 females, 36 diabetics and 49 nondiabetics) to examine the relationships between these markers and bone mineral density (BMD) of the distal radius, as measured by peripheral quantitative computed tomography (pQCT). Trabecular BMD, which is strongly affected by bone metabolism, was significantly negatively correlated with each of the bone formation markers (r=−0.341, p=0.0016, for OC; r=−0.314, p=0.0036, for PINP; r=−0.238, p=0.0315, for BAP), but there was no significant correlation between BMD and any of the bone resorption markers. In multivariate regression analyses (adjusted by age, sex, presence of diabetes, glomerular filtration rate, intact parathyroid hormone, calcium, phosphate, and 1,25-dihydroxyvitamin D), OC and PINP were significantly associated with a decrease in BMD, but BAP was not. In conclusion, we demonstrated that in predialysis CRF patients, BMD of the distal radius, particularly of trabecular bone, is associated with serum OC and PINP levels. OC and PINP are suggested to be possible parameters for the clinical evaluation of the effect of bone metabolism on BMD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Elder G (2002) Pathophysiology and recent advances in the management of renal osteodystrophy. J Bone Miner Res 17:2094–2105

    Google Scholar 

  2. Parfitt AM (1998) A structural approach to renal bone disease. J Bone Miner Res 13:1213–1220

    CAS  PubMed  Google Scholar 

  3. Ho LT, Sprague SM (2002) Renal osteodystrophy in chronic renal failure. Semin Nephrol 22:488–493

    PubMed  Google Scholar 

  4. Slatopolsky E, Gonzalez E, Martin K (2003) Pathogenesis and treatment of renal osteodystrophy. Blood Purif 21:318–326

    Article  PubMed  Google Scholar 

  5. Mazzaferro S, Coen G, Ballanti P, Bondatti F, Bonucci E, Pasquali M, Sardella D, Tomei E, Taggi F (1990) Osteocalcin, iPTH, alkaline phosphatase and hand X-ray scores as predictive indices of histomorphometric parameters in renal osteodystrophy. Nephron 56:261–266

    CAS  PubMed  Google Scholar 

  6. Rix M, Andreassen H, Eskildsen P, Langdahl B, Olgaard K (1999) Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure. Kidney Int 56:1084–1093

    Article  CAS  PubMed  Google Scholar 

  7. Hernandez D, Concepcion MT, Lorenzo V, Martinez ME, Rodriguez A, De Bonis E, Gonzalez-Posada JM, Felsenfeld AJ, Rodriguez M, Torres A (1994) Adynamic bone disease with negative aluminium staining in predialysis patients: prevalence and evolution after maintenance dialysis. Nephrol Dial Transplant 9:517–523

    CAS  PubMed  Google Scholar 

  8. Przedlacki J, Manelius J, Huttunen K (1995) Bone mineral density evaluated by dual-energy X-ray absorptiometry after one-year treatment with calcitriol started in the predialysis phase of chronic renal failure. Nephron 69:433–437

    CAS  PubMed  Google Scholar 

  9. Bervoets AR, Spasovski GB, Behets GJ, Dams G, Polenakovic MH, Zafirovska K, Van Hoof VO, De Broe ME, D’Haese PC (2003) Useful biochemical markers for diagnosing renal osteodystrophy in predialysis end-stage renal failure patients. Am J Kidney Dis 41:997–1007

    Article  CAS  PubMed  Google Scholar 

  10. Fogelman I, Blake GM (2000) Different approaches to bone densitometry. J Nucl Med 41:2015–2025

    CAS  PubMed  Google Scholar 

  11. Looker AC, Bauer DC, Chesnut CH 3rd, Gundberg CM, Hochberg MC, Klee G, Kleerekoper M, Watts NB, Bell NH (2000) Clinical use of biochemical markers of bone remodeling: current status and future directions. Osteoporos Int 11:467–480

    CAS  PubMed  Google Scholar 

  12. Gorai I, Nonaka K, Kishimoto H, Sakata H, Fujii Y, Fujita T (2001) Cut-off values determined for vertebral fracture by peripheral quantitative computed tomography in Japanese women. Osteoporos Int 12:741–748

    Article  CAS  PubMed  Google Scholar 

  13. Lochmuller EM, Muller R, Kuhn V, Lill CA, Eckstein F (2003) Can novel clinical densitometric techniques replace or improve DXA in predicting bone strength in osteoporosis at the hip and other skeletal sites? J Bone Miner Res 18:906–912

    PubMed  Google Scholar 

  14. Watts NB (1999) Clinical utility of biochemical markers of bone remodeling. Clin Chem 45:1359–1368

    CAS  PubMed  Google Scholar 

  15. Coen G, Ballanti P, Bonucci E, Calabria S, Centorrino M, Fassino V, Manni M, Mantella D, Mazzaferro S, Napoletano I, Sardella D, Taggi F (1998) Bone markers in the diagnosis of low turnover osteodystrophy in haemodialysis patients. Nephrol Dial Transplant 13:2294–2302

    Article  CAS  PubMed  Google Scholar 

  16. Couttenye MM, D’Haese PC, Van Hoof VO, Lemoniatou E, Goodman W, Verpooten GA, De Broe ME (1996) Low serum levels of alkaline phosphatase of bone origin: a good marker of adynamic bone disease in haemodialysis patients. Nephrol Dial Transplant 11:1065–1072

    CAS  PubMed  Google Scholar 

  17. Ueda M, Inaba M, Okuno S, Nagasue K, Kitatani K, Ishimura E, Shimizu M, Miki T, Kim M, Nishizawa Y (2002) Clinical usefulness of the serum N-terminal propeptide of type I collagen as a marker of bone formation in hemodialysis patients. Am J Kidney Dis 40:802–809

    Article  CAS  PubMed  Google Scholar 

  18. Ferreira MA (2000) Diagnosis of renal osteodystrophy: when and how to use biochemical markers and non-invasive methods; when bone biopsy is needed. Nephrol Dial Transplant 15[Suppl 5]:8–14

  19. Ha SK, Park CH, Seo JK, Park SH, Kang SW, Choi KH, Lee HY, Han DS (1996) Studies on bone markers and bone mineral density in patients with chronic renal failure. Yonsei Med J 37:350–356

    CAS  PubMed  Google Scholar 

  20. Ishimura E, Nishizawa Y, Inaba M, Matsumoto N, Emoto M, Kawagishi T, Shoji S, Okuno S, Kim M, Miki T, Morii H (1999) Serum levels of 1,25-dihydroxyvitamin D, 24,25-dihydroxyvitamin D, and 25-hydroxyvitamin D in nondialyzed patients with chronic renal failure. Kidney Int 55:1019–1027

    Article  CAS  PubMed  Google Scholar 

  21. Lepage R, Roy L, Brossard JH, Rousseau L, Dorais C, Lazure C, D’Amour P (1998) A non-(1-84) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples. Clin Chem 44:805–809

    CAS  PubMed  Google Scholar 

  22. Fraser WD, Durham BH, Berry JL, Mawer EB (1997) Measurement of plasma 1,25 dihydroxyvitamin D using a novel immunoextraction technique and immunoassay with iodine labelled vitamin D tracer. Ann Clin Biochem 34 ( Pt 6):632–637

    CAS  PubMed  Google Scholar 

  23. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461–470

    Google Scholar 

  24. Shibuya K, Hagino H, Morio Y, Teshima R (2002) Cross-sectional and longitudinal study of osteoporosis in patients with rheumatoid arthritis. Clin Rheumatol 21:150–158

    Article  CAS  PubMed  Google Scholar 

  25. Lochmuller EM, Lill CA, Kuhn V, Schneider E, Eckstein F (2002) Radius bone strength in bending, compression, and falling and its correlation with clinical densitometry at multiple sites. J Bone Miner Res 17:1629–1638

    PubMed  Google Scholar 

  26. Tsurusaki K, Ito M, Hayashi K (2000) Differential effects of menopause and metabolic disease on trabecular and cortical bone assessed by peripheral quantitative computed tomography (pQCT). Br J Radiol 73:14–22

    CAS  PubMed  Google Scholar 

  27. Ashizawa N, Nonaka K, Michikami S, Mizuki T, Amagai H, Tokuyama K, Suzuki M (1999) Tomographical description of tennis-loaded radius: reciprocal relation between bone size and volumetric BMD. J Appl Physiol 86:1347–1351

    Google Scholar 

  28. Gomez B Jr, Ardakani S, Ju J, Jenkins D, Cerelli MJ, Daniloff GY, Kung VT (1995) Monoclonal antibody assay for measuring bone-specific alkaline phosphatase activity in serum. Clin Chem 41:1560–1566

    CAS  PubMed  Google Scholar 

  29. Kumeda Y, Inaba M, Tahara H, Kurioka Y, Ishikawa T, Morii H, Nishizawa Y (2000) Persistent increase in bone turnover in Graves’ patients with subclinical hyperthyroidism. J Clin Endocrinol Metab 85:4157–4161

    CAS  PubMed  Google Scholar 

  30. Inaba M, Nishizawa Y, Mita K, Kumeda Y, Emoto M, Kawagishi T, Ishimura E, Nakatsuka K, Shioi A, Morii H (1999) Poor glycemic control impairs the response of biochemical parameters of bone formation and resorption to exogenous 1,25-dihydroxyvitamin D3 in patients with type 2 diabetes. Osteoporos Int 9:525–531

    Article  CAS  PubMed  Google Scholar 

  31. Takahashi M, Kushida K, Nagano A, Inoue T (2000) Comparison of the analytical and clinical performance characteristics of an N-MID versus an intact osteocalcin immunoradiometric assay. Clin Chim Acta 294:67–76

    Article  CAS  PubMed  Google Scholar 

  32. Tahtela R, Turpeinen M, Sorva R, Karonen SL (1997) The aminoterminal propeptide of type I procollagen: evaluation of a commercial radioimmunoassay kit and values in healthy subjects. Clin Biochem 30:35–40

    Article  PubMed  Google Scholar 

  33. Furumitsu Y, Inaba M, Yukioka K, Yukioka M, Kumeda Y, Azuma Y, Ohta T, Ochi T, Nishizawa Y, Morii H (2000) Levels of serum and synovial fluid pyridinium crosslinks in patients with rheumatoid arthritis. J Rheumatol 27:64–70

    CAS  PubMed  Google Scholar 

  34. Nemoto R, Nakamura I, Nishijima Y, Shiobara K, Shimizu M, Takehara T, Ohta T, Kiyoki M (1997) Serum pyridinoline crosslinks as markers of tumour-induced bone resorption. Br J Urol 80:274–280

    Article  CAS  PubMed  Google Scholar 

  35. Niwa T, Shiobara K, Hamada T, Miyazaki T, Tsukushi S, Uema K, Tsuzuki T (1995) Serum pyridinolines as specific markers of bone resorption in hemodialyzed patients. Clin Chim Acta 235:33–40

    Article  CAS  PubMed  Google Scholar 

  36. Montagnani A, Gonnelli S, Cepollaro C, Mangeri M, Martini S, Franci MB, Campagna MS, Lucani B, Di Paolo N, Bellucci G, Gennari C (2003) A new serum assay to measure N-terminal fragment of telopeptide of type I collagen in patients with renal osteodystrophy. Eur J Intern Med 14:172–177

    Article  CAS  PubMed  Google Scholar 

  37. Hutchison AJ, Whitehouse RW, Boulton HF, Adams JE, Mawer EB, Freemont TJ, Gokal R (1993) Correlation of bone histology with parathyroid hormone, vitamin D3, and radiology in end-stage renal disease. Kidney Int 44:1071–1077

    CAS  PubMed  Google Scholar 

  38. Coen G, Mazzaferro S, Ballanti P, Sardella D, Chicca S, Manni M, Bonucci E, Taggi F (1996) Renal bone disease in 76 patients with varying degrees of predialysis chronic renal failure: a cross-sectional study. Nephrol Dial Transplant 11:813–819

    CAS  PubMed  Google Scholar 

  39. Muller ME, Webber CE, Bouxsein ML (2003) Predicting the failure load of the distal radius. Osteoporos Int 14:345–352

    Article  PubMed  Google Scholar 

  40. Urena P, De Vernejoul MC (1999) Circulating biochemical markers of bone remodeling in uremic patients. Kidney Int 55:2141–2156

    Article  CAS  PubMed  Google Scholar 

  41. Giangregorio L, Blimkie CJ (2002) Skeletal adaptations to alterations in weight-bearing activity: a comparison of models of disuse osteoporosis. Sports Med 32:459–476

    PubMed  Google Scholar 

  42. Iwasaki Y, Yamato H, Murayama H, Sato M, Takahashi T, Ezawa I, Kurokawa K, Fukagawa M (2002) Maintenance of trabecular structure and bone volume by vitamin K(2) in mature rats with long-term tail suspension. J Bone Miner Metab 20:216–222

    Article  CAS  PubMed  Google Scholar 

  43. Liu G, Peacock M (1998) Age-related changes in serum undercarboxylated osteocalcin and its relationships with bone density, bone quality, and hip fracture. Calcif Tissue Int 62:286–289

    Article  CAS  PubMed  Google Scholar 

  44. Ross PD, Knowlton W (1998) Rapid bone loss is associated with increased levels of biochemical markers. J Bone Miner Res 13:297–302

    CAS  PubMed  Google Scholar 

  45. Cheng S, Suominen H, Vaananen K, Kakonen SM, Pettersson K, Heikkinen E (2002) Serum osteocalcin in relation to calcaneal bone mineral density in elderly men and women: a 5-year follow-up. J Bone Miner Metab 20:49–56

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Endocrinology, Metabolism, and Molecular Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan

    Takao Tsuchida, Masaaki Inaba & Yoshiki Nishizawa

  2. Department of Nephrology, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, 545-8585, Osaka, Japan

    Eiji Ishimura, Naoki Matsumoto & Shuichi Jono

  3. Department of Geriatrics, Osaka City University Graduate School of Medicine, Osaka, Japan

    Takami Miki & Hiroshi Naka

Authors
  1. Takao Tsuchida
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eiji Ishimura
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Takami Miki
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Naoki Matsumoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hiroshi Naka
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Shuichi Jono
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Masaaki Inaba
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Yoshiki Nishizawa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eiji Ishimura.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tsuchida, T., Ishimura, E., Miki, T. et al. The clinical significance of serum osteocalcin and N-terminal propeptide of type I collagen in predialysis patients with chronic renal failure. Osteoporos Int 16, 172–179 (2005). https://doi.org/10.1007/s00198-004-1655-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-004-1655-9

Keywords

Search

Navigation